JOHNSON & JOHNSON Cash & Equivalents 2006-2025 | JNJ
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is JOHNSON & JOHNSON's current cash & equivalents?
JOHNSON & JOHNSON (JNJ) annual cash & equivalents for 2025 was $19.71B, a 18.24% decline from 2024. JOHNSON & JOHNSON cash & equivalents for the quarter ending December 28, 2025 was $19.71B.
What was JOHNSON & JOHNSON's cash & equivalents in 2024?
JOHNSON & JOHNSON annual cash & equivalents for 2024 was $24.11B, a 10.27% increase from 2023.
What was JOHNSON & JOHNSON's cash & equivalents in 2023?
JOHNSON & JOHNSON annual cash & equivalents for 2023 was $21.86B, a 26.32% increase from 2019.
What is JOHNSON & JOHNSON's 2-year cash & equivalents CAGR?
JOHNSON & JOHNSON cash & equivalents grew at a compound annual growth rate (CAGR) of 5.05% from FY2023 to FY2025, going from $21.86B to $19.71B over 2 years.
Year-over-year comparison from 10-K annual reports